Guanfeng Yu

Guanfeng Yu

Auto-generated profile, based on publicly available information

Guanfeng Yu

Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2018 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
LWLi Wan
Li Wan
JHJingyong Huang
Jingyong Huang
HNHaizhen Ni
Haizhen Ni
GYGuanfeng Yu
Guanfeng Yu
Abdominal aortic aneurysm (AAA) is a common cardiovascular system disease with high mortality. The aim of this study was to identify potential genes for diagnosis and therapy in AAA. We searched and downloaded mRNA expression data from the Gene Expression Omnibus (GEO) database to identify differentially expressed genes (DEGs) from AAA and normal individuals. Then, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis, transcriptional factors (TFs) network and protein-protein interaction (PPI) network were used to explore the function of genes. Additionally, immunohistochemical (IHC) staining was used to validate the expression of identified genes. Finally, the diagnostic value of identified genes was accessed by receiver operating characteristic (ROC) analysis in GEO database. A total of 1199 DEGs (188 up-regulated and 1011 down-regulated) were identified between AAA and normal individual. KEGG pathway analysis displayed that vascular smooth muscle contraction and pathways in cancer were significantly enriched signal pathway. The top 10 up-regulated and top 10 down-regulated DEGs were used to construct TFs and PPI networks. Some genes with high degrees such as NELL2, CCR7, MGAM, HBB, CSNK2A2, ZBTB16 and FOXO1 were identified to be related to AAA. The consequences of IHC staining showed that CCR7 and PDGFA were up-regulated in tissue samples of AAA. ROC analysis showed that NELL2, CCR7, MGAM, HBB, CSNK2A2, ZBTB16, FOXO1 and PDGFA had the potential diagnostic value for AAA. The identified genes including NELL2, CCR7, MGAM, HBB, CSNK2A2, ZBTB16, FOXO1 and PDGFA might be involved in the pathology of AAA.


3 June 2026 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
WJWenxu Jin
Wenxu Jin
HNHaizhen Ni
Haizhen Ni
CHChongqing Huang
Chongqing Huang
LPLemen Pan
Lemen Pan
YQYihui Qiu
Yihui Qiu
GYGuanfeng Yu
Guanfeng Yu
Background: Carotid artery stenosis is a major cause of ischemic stroke. Various revascularization strategies exist, including Carotid Endarterectomy (CEA), Transfemoral Carotid Artery Stenting (TF-CAS), and Transcervical Carotid Artery Stenting (TC-CAS). This study aimed to compare the perioperative outcomes and six-month follow-up results among patients undergoing TC-CAS, TF-CAS, and CEA for carotid artery stenosis. Methods: A retrospective analysis was performed on 220 patients undergoing carotid revascularization from 2020 to 2024. Patients were divided into three groups: TC-CAS (50), TF-CAS (81), and CEA (89). Primary endpoints included perioperative stroke and complications; secondary endpoints assessed six-month restenosis and stroke/TIA events. Results: Perioperative stroke rates were low and comparable among all groups (TF-CAS 2.5%, TC-CAS 2.0%, CEA 1.1%; P = 0.802). Cranial nerve injury occurred exclusively in the CEA group. Six-month restenosis rates showed no significant difference (TF-CAS 3.7%, TC-CAS 2.0%, CEA 4.5%; P = 0.752), with no stroke or TIA events observed in the TC-CAS group. Hospital costs were significantly lower in the CEA group (25.0 ± 9.8 × 10 3 CNY) compared to TF-CAS (57.6 ± 22.8 × 10 3 CNY) and TC-CAS (56.4 ± 20.1 × 10 3 CNY) ( P < 0.001). Conclusion: TC-CAS is a feasible and promising alternative to TF-CAS and CEA, offering favorable perioperative safety and short-term clinical outcomes. It is particularly suitable for patients with high-risk anatomy, but longer-term studies are required to confirm sustained efficacy.